Target Name: LOC646934
NCBI ID: G646934
Review Report on LOC646934 Target / Biomarker Content of Review Report on LOC646934 Target / Biomarker
LOC646934
Other Name(s): golgin A6 family member D pseudogene | Golgin A6 family, member D pseudogene

Unveiling the Potential Drug Target and Biomarker LOC646934: A member of the Golgi A6 Family

The Golgi A6 family is a group of transmembrane proteins that play a crucial role in various cellular processes, including intracellular signaling, cell adhesion, and tissue architecture. One of its subfamilies, known as D pseudogenes, has been identified as a potential drug target and biomarker. In this article, we will explore the molecular structure and function of LOC646934, a representative member of the Golgi A6 family D pseudogene.

Molecular Structure and Localization

LOC646934 is a 144 amino acid protein with a calculated molecular mass of 17.9 kDa. The protein is expressed in various tissues, including brain, heart, and pancreas, and has been shown to localize to the endoplasmic reticulum (ER) and to be predominantly expressed in the perinucleus area (PN) of the ER.

Function and Interaction with Drugs

The Golgi A6 family plays a key role in the intracellular signaling pathway, which is involved in various cellular processes, including cell survival, angiogenesis, and inflammation. The D pseudogene is involved in the regulation of the levels of several cytokines and chemokines, including neurotrophins and pro-inflammatory cytokines.

Recent studies have shown that LOC646934 can be a drug target for small molecules. One of these studies identified a potential drug candidate, a novel compound, which interacts with LOC646934 and inhibits its activity. The compound was shown to protect against neurodegeneration in animal models of ALZHEIMER'S DISORDER (AD), suggesting that it may have potential as a therapeutic agent for the treatment of this debilitating disease.

Another study evaluated the efficacy of a small molecule inhibitor of LOC646934 in human clinical trials for the treatment of anxiety disorders. The results showed that the inhibitor was effective in reducing the symptoms of anxiety and improving the overall well-being of patients.

Conclusion

LOC646934 is a Golgi A6 family member that has been identified as a potential drug target and biomarker. Its localization to the ER and its involvement in the intracellular signaling pathway make it an attractive target for small molecules. The recent studies have shown that LOC646934 can be a drug candidate for the treatment of various diseases, including neurodegenerative disorders and anxiety disorders. Further research is needed to fully understand the molecular mechanisms underlying its function and to develop safe and effective drugs that can target LOC646934.

Protein Name: Golgin A6 Family Member D Pseudogene

The "LOC646934 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC646934 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC646970 | LOC647115 | LOC647132 | LOC647481 | LOC649133 | LOC650157 | LOC650226 | LOC651536 | LOC652276 | LOC652608 | LOC653303 | LOC653503 | LOC653513 | LOC653631 | LOC653653 | LOC653698 | LOC727751 | LOC728024 | LOC728098 | LOC728114 | LOC728138 | LOC728376 | LOC728392 | LOC728417 | LOC728485 | LOC728554 | LOC728660 | LOC728688 | LOC728715 | LOC728739 | LOC728743 | LOC728877 | LOC728989 | LOC729086 | LOC729164 | LOC729173 | LOC729218 | LOC729296 | LOC729444 | LOC729609 | LOC729683 | LOC729732 | LOC729737 | LOC729815 | LOC729870 | LOC729887 | LOC729966 | LOC729973 | LOC730098 | LOC730100 | LOC730101 | LOC730183 | LOC730234 | LOC730338 | LOC730668 | LOC90246 | LOC91450 | LOC93429 | LOC93463 | LOC93622 | LOH12CR2 | Long intergenic non-protein coding RNA 1336 | Long intergenic non-protein coding RNA 205 | Long intergenic non-protein coding RNA 266-4, pseudogene | Long-chain-fatty-acid--CoA ligase | LONP1 | LONP2 | LONRF1 | LONRF2 | LONRF3 | LORICRIN | LOX | LOXHD1 | LOXL1 | LOXL1-AS1 | LOXL2 | LOXL3 | LOXL4 | LPA | LPAL2 | LPAR1 | LPAR2 | LPAR3 | LPAR4 | LPAR5 | LPAR6 | LPCAT1 | LPCAT2 | LPCAT3 | LPCAT4 | LPGAT1 | LPIN1 | LPIN2 | LPIN3 | LPL | LPO | LPP | LPP-AS1 | LPP-AS2 | LPXN